Yuichi Katanami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuichi Katanami has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Norio Ohmagari
Diseases Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo 162-8655, Japan; AMR Clinical Reference Center, National Centre for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo 162-8655, Japan
5 shared publicationsKayoko Hayakawa
Diseases Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo 162-8655, Japan; AMR Clinical Reference Center, National Centre for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo 162-8655, Japan
4 shared publicationsKei Yamamoto
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
4 shared publicationsNozomi Takeshita
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
4 shared publications- Kayoko Hayakawa
Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security
3 shared publications Satoshi Kutsuna
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
3 shared publications
Latest Publications
- 1 May 2020
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 26 (5) , 429-437
Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A scoping review
- 1 May 2020
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 26 (5) , 429-437
Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A scoping review
- 1 February 2019
- Published by Elsevier in American Journal of Infection Control
- Vol. 47 (2) , 208-210
Comparison of the epidemiology and microbiology of peripheral line– and central line–associated bloodstream infections
- 1 February 2019
- Published by Elsevier in American Journal of Infection Control
- Vol. 47 (2) , 208-210
Comparison of the epidemiology and microbiology of peripheral line– and central line–associated bloodstream infections
- 1 December 2018
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (12) , 969-974
Real-time PCR investigation of the prevalence of Fusobacterium necrophorum in patients with pharyngitis in Japan
- 1 December 2018
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (12) , 969-974
Real-time PCR investigation of the prevalence of Fusobacterium necrophorum in patients with pharyngitis in Japan
- 25 May 2018
- Published by Japanese Society of Environmental Infections in Japanese Journal of Infection Prevention and Control
- Vol. 33 (3) , 111-116
Evaluation of Denominators in Surveillance of Peripheral Venous Catheter Related Blood Stream Infections: Correlation between Patient Days and Catheter Days
末梢静脈カテーテル関連血流感染症(PCRBSI:peripheral venous catheter-related blood stream infection)の発生率のサーベイランスにおいて,カテーテル日を分母とする場合と比べ入院人日を分母としても評価が可能かどうか検討した. 単一の急性期病院において2012年4月~2015年9月までの入院人日と末梢静脈カテーテル日を医療情報システムより抽出し,両者の正規性を確認しPearsonの相関係数を求めた.また,入院人日とカテーテル日を分母としてそれぞれPCRBSI発生率を計算し,両者の月毎の動向を比較した. 平均入院人日は月20,320,平均カテーテル日は月11,178だった.入院人日とカテーテル日の相関については,相関係数=0.851(P値<0.01)であり,強い正の相関が認められた.PCRBSI発生率のグラフでは,増減方向は概ね一致していた. 同一施設内でPCRBSI発生率の推移を評価する場合は,入院人日を分母としてもカテーテル日と同様の推移の傾向を把握できると考えられた.
- 25 May 2018
- Published by Japanese Society of Environmental Infections in Japanese Journal of Infection Prevention and Control
- Vol. 33 (3) , 111-116
Evaluation of Denominators in Surveillance of Peripheral Venous Catheter Related Blood Stream Infections: Correlation between Patient Days and Catheter Days
末梢静脈カテーテル関連血流感染症(PCRBSI:peripheral venous catheter-related blood stream infection)の発生率のサーベイランスにおいて,カテーテル日を分母とする場合と比べ入院人日を分母としても評価が可能かどうか検討した. 単一の急性期病院において2012年4月~2015年9月までの入院人日と末梢静脈カテーテル日を医療情報システムより抽出し,両者の正規性を確認しPearsonの相関係数を求めた.また,入院人日とカテーテル日を分母としてそれぞれPCRBSI発生率を計算し,両者の月毎の動向を比較した. 平均入院人日は月20,320,平均カテーテル日は月11,178だった.入院人日とカテーテル日の相関については,相関係数=0.851(P値<0.01)であり,強い正の相関が認められた.PCRBSI発生率のグラフでは,増減方向は概ね一致していた. 同一施設内でPCRBSI発生率の推移を評価する場合は,入院人日を分母としてもカテーテル日と同様の推移の傾向を把握できると考えられた.
- Open Access
- 24 July 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0181548
Impact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: A prospective study of community-onset bacteremia in a tertiary hospital in Japan
Rapid identification of positive blood cultures is important for initiation of optimal treatment in septic patients. Effects of automated, microarray-based rapid identification systems on antibiotic prescription against community-onset bacteremia (COB) remain unclear. We prospectively enrolled 177 patients with 185 COB episodes (occurring within 72 h of admission) over 17 months. Bacteremia episodes due to gram-positive bacteria (GP) and gram-negative bacteria (GN) in the same patient were counted separately. For GP bacteremia, patients with ≥2 sets of positive blood cultures were included. The primary study objective was evaluating the rates of antibiotic prescription changes within 2 days of rapid identification using the Verigene system. Bacteremia due to GN and GP included 144/185 (77.8%) and 41/185 (22.2%) episodes, respectively. Antibiotic prescription changes occurred in 51/185 cases (27.6% [95%CI:21.3–34.6%]) after Verigene analysis and 70/185 cases (37.8% [30.8–45.2%]) after conventional identification and susceptibility testing. Prescription changes after Verigene identification were more frequent in GP (17/41[41.5%]) than in GN (34/144[23.5%]). Among bacteremia due to single pathogen targeted by Verigene test, bacterial identification agreement between the two tests was high (GP: 38/39[97.4%], GN: 116/116[100%]). The Verigene test correctly predicted targeted antimicrobial resistance. The durations between the initiation of incubation and reporting of the results for the Verigene system and conventional test was 28.3 h (IQR: 25.8–43.4 h) and 90.6 h (68.3–118.4 h), respectively. In only four of the seven episodes of COB in which two isolates were identified by conventional tests, the Verigene test correctly identified both organisms. We observed a high rate of antibiotic prescription changes after the Verigene test in a population with COB especially in GP. The Verigene test would be a useful tool in antimicrobial stewardship programs among patients with COB.
- 24 July 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0181548
Open AccessImpact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: A prospective study of community-onset bacteremia in a tertiary hospital in Japan
Rapid identification of positive blood cultures is important for initiation of optimal treatment in septic patients. Effects of automated, microarray-based rapid identification systems on antibiotic prescription against community-onset bacteremia (COB) remain unclear. We prospectively enrolled 177 patients with 185 COB episodes (occurring within 72 h of admission) over 17 months. Bacteremia episodes due to gram-positive bacteria (GP) and gram-negative bacteria (GN) in the same patient were counted separately. For GP bacteremia, patients with ≥2 sets of positive blood cultures were included. The primary study objective was evaluating the rates of antibiotic prescription changes within 2 days of rapid identification using the Verigene system. Bacteremia due to GN and GP included 144/185 (77.8%) and 41/185 (22.2%) episodes, respectively. Antibiotic prescription changes occurred in 51/185 cases (27.6% [95%CI:21.3–34.6%]) after Verigene analysis and 70/185 cases (37.8% [30.8–45.2%]) after conventional identification and susceptibility testing. Prescription changes after Verigene identification were more frequent in GP (17/41[41.5%]) than in GN (34/144[23.5%]). Among bacteremia due to single pathogen targeted by Verigene test, bacterial identification agreement between the two tests was high (GP: 38/39[97.4%], GN: 116/116[100%]). The Verigene test correctly predicted targeted antimicrobial resistance. The durations between the initiation of incubation and reporting of the results for the Verigene system and conventional test was 28.3 h (IQR: 25.8–43.4 h) and 90.6 h (68.3–118.4 h), respectively. In only four of the seven episodes of COB in which two isolates were identified by conventional tests, the Verigene test correctly identified both organisms. We observed a high rate of antibiotic prescription changes after the Verigene test in a population with COB especially in GP. The Verigene test would be a useful tool in antimicrobial stewardship programs among patients with COB.
- 1 April 2017
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 23 (4) , 241-244
A fatal case of melioidosis with pancytopenia in a traveler from Indonesia
- 1 April 2017
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 23 (4) , 241-244
A fatal case of melioidosis with pancytopenia in a traveler from Indonesia
- 1 January 2017
- Published by Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis in Japanese Journal of Infectious Diseases
- Vol. 70 (6) , 675-677
A Case of Dengue Fever Imported from Burkina Faso to Japan in October 2016
Dengue fever remains underreported in Africa due to a lack of awareness among healthcare providers, the presence of other febrile illnesses, and insufficient laboratory testing. We present a case of dengue fever imported from Burkina Faso to Japan, where an outbreak of dengue was reported on October 18, 2016. Phylogenetic analysis revealed that the isolate from our patient belonged to a distinct cluster of sylvatic dengue viruses, suggesting that dengue viruses have been maintained in mosquitoes and human cycles in Burkina Faso for more than 30 years.
- 1 January 2017
- Published by Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis in Japanese Journal of Infectious Diseases
- Vol. 70 (6) , 675-677
A Case of Dengue Fever Imported from Burkina Faso to Japan in October 2016
Dengue fever remains underreported in Africa due to a lack of awareness among healthcare providers, the presence of other febrile illnesses, and insufficient laboratory testing. We present a case of dengue fever imported from Burkina Faso to Japan, where an outbreak of dengue was reported on October 18, 2016. Phylogenetic analysis revealed that the isolate from our patient belonged to a distinct cluster of sylvatic dengue viruses, suggesting that dengue viruses have been maintained in mosquitoes and human cycles in Burkina Faso for more than 30 years.